Press Releases
Results
showing 1-10 of 173
AVAC Applauds Appointment of Mark Dybul as Executive Director of the Global Fund
AVAC applauds the appointment of Mark Dybul as Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. His return to the Global Fund comes at a pivotal moment for global health, as funding pressures, political threats and persistent inequities threaten hard-won progress against the three diseases.
AVAC, Access Bridge Call for Accelerated Ambition to Reach at Least Three Million People with Lenacapavir for HIV Prevention by the End of 2027
AVAC and Access Bridge today issued a global call to action urging governments, donors, manufacturers, implementers, and advocates to work toward a bold but achievable goal: reaching at least three million people with injectable lenacapavir (LEN) for HIV prevention by the end of 2027.
Prevention Option:
MEDIA ALERT: 139 Organizations Urge Congress to Act on Three Imminent Threats to HIV Research Ahead of Midterms
WASHINGTON, D.C. — October 20, 2026 — Just two weeks before the midterm elections, 138 organizations have signed an urgent letter to congressional appropriations leaders, calling for immediate action to protect federal HIV research from three...
AVAC Says Stop the Waste, Fraud and Abuse in the Persecution of Tony Fauci
AVAC vehemently opposes the decision by the U.S. Senate Homeland Security and Governmental Affairs Committee to hold Dr. Anthony Fauci in contempt for his refusal to answer questions during last week’s hearing on the COVID-19 response. Certain members of the committee have made it clear of their intentions and attempt to pin the shortcomings of the U.S. response to COVID-19 by blaming and dragging renowned government scientists and public health practitioners such as Dr. Fauci through politicized proceedings without any evidence and using conspiratorial conjecture.
AVAC and Access Bridge Applaud Monthly PrEP Pill Access Announcement; Call for Speed, Scale and Equity in Future Monthly Oral Alimatravir Introduction
AVAC and Access Bridge applaud Merck’s announcement today that it has granted seven direct licenses to generic manufacturers to produce their investigational monthly pill for HIV prevention, known as MK-8527, or alimatravir, while Phase 3 clinical trials are still enrolling.
Prevention Option:
HIV Prevention Advocates Applaud South Africa’s Introduction of Lenacapavir for PrEP
In a landmark moment, South Africa today became the 9th African country to introduce lencapavir (LEN) for HIV prevention. HIV prevention partners AVAC, Advocates for the Prevention of HIV in Africa (APHA), and Access Bridge welcomed today’s news of increased commitments and support from the Global Fund, while calling for further ensure access is realized and impact achieved.
Three Million is a Step Forward, But Not Enough
In response to the the US State Department, Global Fund, and Gilead announcement of increased volume commitments for lenacapavir (LEN) for HIV prevention, AVAC and Access Bridge call for global leaders to do even more to ensure meaningful, expanded access.
AVAC Mourns the Death of Stephen Lewis
Stephen Lewis was a politician and diplomat who deeply valued the essential role of communities in the HIV response. His was a very rare and impactful role model, and all of us at AVAC are deeply saddened by his passing.
Prevention Option:
AVAC Calls for the Immediate Rejection of the Global Gag Rule and Any Expansion of it
AVAC calls for the immediate rejection of the Global Gag Rule and any expansion of it and urges US lawmakers to uphold science, human rights, and public health.
AVAC Board Member Jeanne Marrazzo named CEO of IDSA
AVAC enthusiastically applauds the selection of Jeanne Marrazzo, MD, to serve as the new chief executive officer of the Infectious Diseases Society of America (IDSA).
Prevention Option:
showing 1-10 of 173